MedPath

EGFR-mutation analysis of circulating tumor DNA with high sensitive methods and concordance to effect of EGFR-TKI.

Not Applicable
Recruiting
Conditions
non-small cell lung cancer
Registration Number
JPRN-UMIN000016348
Lead Sponsor
Miyagi Cancer Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1.Received EGFR-TKI before this study 2.Interstitial pmeumonitis or pulmonary fibrosis apparent on chest X-ray 3.Concomitant other malignancies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath